We’re living in an era of “tweakments,” where minimally invasive cosmetic procedures like Botox and filler have been reduced to nothing more than an ordinary step in one’s skincare regimen. But what ...

Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin® (recombinant botulinum toxin type A, project ...

AbbVie received a Complete Response Letter (CRL) from the FDA for its Biologics License Application (BLA) for ...

The use of toxin botulinum-A is one of the most rapidly growing areas in cosmetic dermatology. There is always news about this incredible substance. There are new indications, new techniques, and new ...

SAN DIEGO — The potential adverse effects of botulinum toxin and fillers aren’t just clinical, a dermatologist warned colleagues. Physicians are at risk of legal consequences if they aren’t careful ...

Please provide your email address to receive an email when new articles are posted on . Some botulinum toxin type A injection formulations have a faster onset, whereas others were shown to last longer ...

Botulinum toxin A (BTX-A) has emerged as an indispensable intervention for managing spasticity in children with cerebral palsy (CP). By inhibiting acetylcholine release at the neuromuscular junction, ...

Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, ...

The FDA issued a complete response letter regarding AbbVie’s biologics license application for trenibotulinumtoxinE, a ...